Ruichen Zhao
Impact in
- Pharmaceutical Science top 5%
- Advanced Drug Delivery Systems
- Cancer Research top 10%
- MicroRNA in disease regulation
Papers in
-
- RNA Interference and Gene Delivery 12
- Advanced biosensing and bioanalysis techniques 6
- Extracellular vesicles in disease 5
-
- MicroRNA in disease regulation 4
- Co-authors
- Xin Zhang (15 shared papers)Zhiguo Lü (15 shared papers)Jun Yang (7 shared papers)Weihong Ji (10 shared papers)Huan Peng (10 shared papers)Jie Shen (6 shared papers)Yanyue Wu (7 shared papers)Yan Li (1 shared paper)
- Journals
- Chinese Chemical Letters (2 papers)Bioactive Materials (2 papers)Theranostics (2 papers)Life (2 papers)Advanced Materials (2 papers)
- Partner nations
- China
In The Last Decade
Ruichen Zhao
25 papers receiving 810 citations
Hit Papers
Peers
Comparison fields: 5 of 95
- Pharmaceutical Science 103
- Cancer Research 179
- Biomaterials 137
- Molecular Biology 491
- Neurology 56
Countries citing papers authored by Ruichen Zhao
This map shows the geographic impact of Ruichen Zhao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruichen Zhao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruichen Zhao more than expected).
Fields of papers citing papers by Ruichen Zhao
This network shows the impact of papers produced by Ruichen Zhao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruichen Zhao. The network helps show where Ruichen Zhao may publish in the future.
Co-authors
The 25 scholars most cited alongside Ruichen Zhao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Intranasal Administration of Self-Oriented Nanocarriers Based on Therapeutic Exosomes for Synergistic Treatment of Parkinson’s Disease Hit paper breakdown → | 2022 | 155 |
| 2 | 2020 | 154 | |
| 3 | 2020 | 74 | |
| 4 | 2023 | 71 | |
| 5 | 2021 | 65 | |
| 6 | 2022 | 64 | |
| 7 | 2021 | 39 | |
| 8 | 2020 | 33 | |
| 9 | 2021 | 29 | |
| 10 | 2020 | 26 | |
| 11 | 2021 | 18 | |
| 12 | 2020 | 13 | |
| 13 | 2023 | 12 | |
| 14 | 2023 | 11 | |
| 15 | 2021 | 11 | |
| 16 | 2022 | 9 | |
| 17 | 2021 | 8 | |
| 18 | 2021 | 8 | |
| 19 | 2023 | 6 | |
| 20 | 2025 | 3 |
About Ruichen Zhao
Ruichen Zhao is a scholar working on Molecular Biology, Cancer Research, Cellular and Molecular Neuroscience, Pharmaceutical Science and Biomaterials, having authored 27 papers that have together received 818 indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (12 papers), Advanced biosensing and bioanalysis techniques (6 papers), Extracellular vesicles in disease (5 papers), MicroRNA in disease regulation (4 papers), Nanoparticle-Based Drug Delivery (3 papers), Neuroinflammation and Neurodegeneration Mechanisms (3 papers), Advanced Drug Delivery Systems (3 papers) and Advanced Nanomaterials in Catalysis (3 papers). The work is most often cited by research in Pharmaceutical Science (103 citations), Cancer Research (179 citations), Biomaterials (137 citations), Molecular Biology (491 citations) and Neurology (56 citations). Ruichen Zhao has collaborated with scholars based in China. Frequent co-authors include Xin Zhang, Zhiguo Lü, Jun Yang, Weihong Ji, Huan Peng, Jie Shen, Yanyue Wu, Yan Li, Qiulian Hao and Jianze Wang. Their work appears in journals such as Chinese Chemical Letters, Bioactive Materials, Theranostics, Life and Advanced Materials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.